IL1B and arthritic joint disease: Similarly, it was demonstrated that 0.5% CLA (c9,t11) reduced arthritis symptoms through the reduction of IL-6 and IL-1β levels in mice comparable to a 1.5 mg/kg dose of celecoxib [189].